(Q38074087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

Role of liver biopsy in the era of direct-acting antivirals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Syed-mohammed Jafri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Stuart C Gordon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

1 reference

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

Current gastroenterology reports

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Chronic hepatitis C in patients with persistently normal alanine transaminase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Preemptive therapy for hepatitis C virus after living-donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Non-invasive markers for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Prevalence and Characteristics of Pain Induced by Percutaneous Liver Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Use of the AST to platelet ratio index in HCV/HIV co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Assessment of hepatic fibrosis with magnetic resonance elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0307-Z

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

12 December 2020

Staging Liver Fibrosis in Hepatitis C: A Challenge for This Decade

1 reference

12 December 2020

Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice

1 reference

12 December 2020

Can aspartate aminotransferase to platelet ratio index replace liver biopsy in chronic hepatitis C?

1 reference

12 December 2020

Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study

1 reference

12 December 2020

1 reference

12 December 2020

FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C

1 reference

12 December 2020

One-second needle biopsy of the liver

1 reference

12 December 2020

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

12 December 2020

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

1 reference

12 December 2020

Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis

1 reference

12 December 2020

Guidelines for the diagnosis of uncomplicated cirrhosis

1 reference

12 December 2020

FibroMeters: a family of blood tests for liver fibrosis

1 reference

12 December 2020

Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients

1 reference

12 December 2020

1 reference

12 December 2020

Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI)

1 reference

12 December 2020

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

12 December 2020

Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living liver and kidney donors

1 reference

12 December 2020

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

12 December 2020

External validation of FibroIndex

1 reference

12 December 2020

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

12 December 2020

Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection

1 reference

12 December 2020

Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations

1 reference

12 December 2020

10.1007/S11894-012-0307-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 February 2020

1019684395

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23319086%20AND%20SRC:MED&resulttype=core&format=json